Garcia Marino (CIK 1669866) reported 8 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-03-17). Recent activity: Buy DNTH (59,700 shares), Buy DNTH (5,592 shares), Buy DNTH (122,918 shares), Sell DNTH (43,505 shares), Sell DNTH (65,517 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-03-17 | Dianthus Therapeutics, Inc. /DE/ (DNTH) | CEO AND PRESIDENT | Buy | 59,700 | $399,990 |
| 2026-03-17 | Dianthus Therapeutics, Inc. /DE/ (DNTH) | CEO AND PRESIDENT | Buy | 5,592 | $99,985 |
| 2026-03-13 | Dianthus Therapeutics, Inc. /DE/ (DNTH) | CEO AND PRESIDENT | Buy | 122,918 | $823,551 |
| 2026-03-13 | Dianthus Therapeutics, Inc. /DE/ (DNTH) | CEO AND PRESIDENT | Sell | 43,505 | $3.5M |
| 2026-03-13 | Dianthus Therapeutics, Inc. /DE/ (DNTH) | CEO AND PRESIDENT | Sell | 65,517 | $5.4M |
| 2026-03-13 | Dianthus Therapeutics, Inc. /DE/ (DNTH) | CEO AND PRESIDENT | Sell | 12,796 | $1.1M |
| 2026-03-13 | Dianthus Therapeutics, Inc. /DE/ (DNTH) | CEO AND PRESIDENT | Sell | 200 | $16,676 |
| 2026-03-13 | Dianthus Therapeutics, Inc. /DE/ (DNTH) | CEO AND PRESIDENT | Sell | 900 | $76,977 |
Source: SEC Form 4 filings · as of 2026-03-17